Abstract
e12656Background: The biosimilar of trastuzumab (Herticad ®) used in Russian clinical practice since March 2016, but the effectiveness, safety and economic rationality of biosimilar of trastuzumab ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have